SHARMEH opened higher at ₹84.75, compared with its previous close of ₹80.23. In the last trading session on 12 Nov 2026, the stock traded between ₹80.20 and ₹84.75, with an average traded price of ₹80.64. It showed a sideways intraday trend.
An investment of ₹10,000 made 3 years ago in SHARMEH is now worth
₹ 33,954.00
Giving a profit of
₹ 23,954.00 (239.54%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.03 (-0.04%)
Day High
₹84.75
Day Low
₹80.20
Day Open
₹84.75
Prev Close
₹80.23
Volume
140
Value Traded
₹0.00 Cr
1W Return
-7.87%
1M Return
-2.31%
3M Return
-15.58%
6M Return
-19.80%
1Y Return
-36.35%
Market Cap (₹ Cr.)
26
PE Ratio
23.30
PB Ratio
1.97
Dividend Yield
-
ROE
9.06%
ROCE
14.24%
Book Value (₹)
40.75
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-7.87%
6 Weeks
-
1 Month
-2.31%
3 Months
-15.58%
9 Months
-25.60%
No data available.
Sharma East India Q2FY27 Results: Net profit falls 17% YoY to ₹26 lakh
Net profit fell 17.4% YoY to ₹26.24 lakh in Q2FY27. Revenue from operations grew 10.4% YoY to ₹1,035.89 lakh. Finance costs nearly doubled to ₹19.91 lakh, impacting profitability. Trade receivables increased by ₹408.20 lakh during H1FY27. Cash and cash equivalents dropped to ₹29.25 lakh as on September 30, 2026.
5 days agoSharma East India Hospitals passes all AGM resolutions unanimously
All three ordinary resolutions passed unanimously at the 37th AGM. Total of 8,23,000 votes cast in favor across all agenda items. Meeting held via video conferencing on September 30, 2026. Radhika Sathe re-appointed as Director without opposition.
1mo agoSharma East India closes trading window ahead of Q2FY27 results
Trading window closes October 1, 2026, for all Designated Persons. Closure covers Q2FY27 standalone un-audited financial results. Window reopens 48 hours after results become publicly available. Notice filed with BSE Limited pursuant to April 2, 2019 circular.
1mo agoSharma East India Hospitals files FY26 report, schedules AGM for September 30
Sharma East India Hospitals filed its FY26 annual report with total income of ₹3,608.91 lakh. Net profit after tax stood at ₹124.27 lakh, marginally down from ₹124.43 lakh in FY25. The 37th AGM is scheduled for September 30, 2026, via video conferencing. Radhika Sathe is up for re-appointment as a director retiring by rotation. No dividend was declared; profits will be reinvested into the business.
2mo agoSharma East India closes trading window for Q1FY27 results
Sharma East India Hospitals and Medical Research Ltd closed its trading window on July 1, 2026, for designated persons prior to the release of Q1FY27 standalone unaudited financial results. The window will open 48 hours after the results are announced, in compliance with BSE regulations.
4mo agoSharma East India Hospitals reports FY26 net profit of ₹124.27 lakh
Sharma East India Hospitals and Medical Research Limited reported a net profit of ₹124.27 lakh for FY26, with total income from operations rising to ₹3,608.91 lakh. For Q4FY26, net profit stood at ₹42.92 lakh on a total income of ₹748.71 lakh. The Board approved the audited results on May 30, 2026.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹8,579.50 | +0.76% | ₹1,23,360.05 | 52.40 | +14.42% | |
| ₹943.15 | -0.33% | ₹91,797.76 | 66.60 | -14.54% | |
| ₹685.65 | +1.35% | ₹90,188.84 | 98.20 | +16.21% | |
| ₹722.35 | -1.84% | ₹62,965.26 | 113.80 | +6.02% | |
| ₹762.00 | +0.26% | ₹57,527.81 | 54.00 | -21.39% | |
| ₹1,444.00 | +0.30% | ₹38,825.09 | 63.10 | +23.02% | |
| ₹1,852.40 | +0.67% | ₹37,855.80 | 43.70 | +5.30% | |
| ₹1,978.40 | -1.51% | ₹33,207.21 | 57.30 | +28.44% | |
| ₹723.80 | -0.48% | ₹30,400.07 | 155.10 | +5.30% | |
| ₹447.90 | +0.02% | ₹18,080.34 | 97.10 | -32.53% | |
| ₹554.50 | +0.59% | ₹17,579.10 | 85.10 | +8.49% | |
| ₹668.40 | +0.35% | ₹16,106.22 | 39.00 | +31.37% |
An investment of ₹10,000 made 3 years ago in SHARMEH is now worth
₹ 33,954.00
Giving a profit of
₹ 23,954.00 (239.54%)
Note: Past profits do not guarantee future returns.
